Search Results - "Xu, Mingjiang"

Refine Results
  1. 1

    Animals models of gastrointestinal and liver diseases. Animal models of alcohol-induced liver disease: pathophysiology, translational relevance, and challenges by Mathews, Stephanie, Xu, Mingjiang, Wang, Hua, Bertola, Adeline, Gao, Bin

    “…Over the last four decades, chronic ethanol feeding studies in rodents using either ad libitum feeding or intragastric infusion models have significantly…”
    Get more information
    Journal Article
  2. 2
  3. 3

    Leucine supplementation increases SIRT1 expression and prevents mitochondrial dysfunction and metabolic disorders in high-fat diet-induced obese mice by Li, Hongliang, Xu, Mingjiang, Lee, Jiyeon, He, Chaoyong, Xie, Zhonglin

    “…Leucine supplementation has been shown to prevent high-fat diet (HFD)-induced obesity, hyperglycemia, and dyslipidemia in animal models, but the underlying…”
    Get more information
    Journal Article
  4. 4

    Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies by Li, Zhe, Cai, Xiaoqiang, Cai, Chen-Leng, Wang, Jiapeng, Zhang, Wenyong, Petersen, Bruce E., Yang, Feng-Chun, Xu, Mingjiang

    Published in Blood (27-10-2011)
    “…TET2 is mutated/deleted with high frequencies in multiple forms of myeloid malignancies including MDS, CMML, MPN, and AML. However, little is known regarding…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    The presence of JAK2V617F mutation in the liver endothelial cells of patients with Budd-Chiari syndrome by Sozer, Selcuk, Fiel, Maria Isabel, Schiano, Thomas, Xu, Mingjiang, Mascarenhas, John, Hoffman, Ronald

    Published in Blood (21-05-2009)
    “…Patients with myeloproliferative disorders are at a high risk of developing thrombotic events. Several investigators have hypothesized that endothelial cell…”
    Get full text
    Journal Article
  8. 8

    Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies by He, Yonghan, Khan, Sajid, Huo, Zhiguang, Lv, Dongwen, Zhang, Xuan, Liu, Xingui, Yuan, Yaxia, Hromas, Robert, Xu, Mingjiang, Zheng, Guangrong, Zhou, Daohong

    Published in Journal of hematology and oncology (27-07-2020)
    “…Proteolysis targeting chimeras (PROTACs) are heterobifunctional small molecules that utilize the ubiquitin proteasome system (UPS) to degrade proteins of…”
    Get full text
    Journal Article
  9. 9

    Hepatocytes and neutrophils cooperatively suppress bacterial infection by differentially regulating lipocalin‐2 and neutrophil extracellular traps by Li, Hongjie, Feng, Dechun, Cai, Yan, Liu, Yudong, Xu, Mingjiang, Xiang, Xiaogang, Zhou, Zhou, Xia, Qiang, Kaplan, Mariana J., Kong, Xiaoni, Gao, Bin

    Published in Hepatology (Baltimore, Md.) (01-10-2018)
    “…Lipocalin‐2 (LCN2), also known as neutrophil gelatinase‐associated lipocalin (NGAL), a key antibacterial protein, is highly elevated in patients with end‐stage…”
    Get full text
    Journal Article
  10. 10

    Ten-eleven translocation 2 interacts with forkhead box O3 and regulates adult neurogenesis by Li, Xuekun, Yao, Bing, Chen, Li, Kang, Yunhee, Li, Yujing, Cheng, Ying, Li, Liping, Lin, Li, Wang, Zhiqin, Wang, Mengli, Pan, Feng, Dai, Qing, Zhang, Wei, Wu, Hao, Shu, Qiang, Qin, Zhaohui, He, Chuan, Xu, Mingjiang, Jin, Peng

    Published in Nature communications (29-06-2017)
    “…Emerging evidence suggests that active DNA demethylation machinery plays important epigenetic roles in mammalian adult neurogenesis; however, the precise…”
    Get full text
    Journal Article
  11. 11

    Loss of Asxl1 leads to myelodysplastic syndrome–like disease in mice by Wang, Jiapeng, Li, Zhaomin, He, Yongzheng, Pan, Feng, Chen, Shi, Rhodes, Steven, Nguyen, Lihn, Yuan, Jin, Jiang, Li, Yang, Xianlin, Weeks, Ophelia, Liu, Ziyue, Zhou, Jiehao, Ni, Hongyu, Cai, Chen-Leng, Xu, Mingjiang, Yang, Feng-Chun

    Published in Blood (23-01-2014)
    “…ASXL1 is mutated/deleted with high frequencies in multiple forms of myeloid malignancies, and its alterations are associated with poor prognosis. De novo ASXL1…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15

    Macrophage DCLK1 promotes atherosclerosis via binding to IKKβ and inducing inflammatory responses by Huang, Zhuqi, Shen, Sirui, Han, Xue, Li, Weixin, Luo, Wu, Lin, Liming, Xu, Mingjiang, Wang, Yi, Huang, Weijian, Wu, Gaojun, Liang, Guang

    Published in EMBO molecular medicine (08-05-2023)
    “…Atherosclerosis is a chronic inflammatory disease with high morbidity and mortality rates worldwide. Doublecortin‐like kinase 1 (DCLK1), a…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Six1 regulates leukemia stem cell maintenance in acute myeloid leukemia by Chu, Yajing, Chen, Yangpeng, Li, Mengke, Shi, Deyang, Wang, Bichen, Lian, Yu, Cheng, Xuelian, Wang, Xiaomin, Xu, Mingjiang, Cheng, Tao, Shi, Jun, Yuan, Weiping

    Published in Cancer science (01-07-2019)
    “…Molecular genetic changes in acute myeloid leukemia (AML) play crucial roles in leukemogenesis, including recurrent chromosome translocations,…”
    Get full text
    Journal Article
  18. 18

    Combined Loss of Tet1 and Tet2 Promotes B Cell, but Not Myeloid Malignancies, in Mice by Zhao, Zhigang, Chen, Li, Dawlaty, Meelad M., Pan, Feng, Weeks, Ophelia, Zhou, Yuan, Cao, Zeng, Shi, Hui, Wang, Jiapeng, Lin, Li, Chen, Shi, Yuan, Weiping, Qin, Zhaohui, Ni, Hongyu, Nimer, Stephen D., Yang, Feng-Chun, Jaenisch, Rudolf, Jin, Peng, Xu, Mingjiang

    Published in Cell reports (Cambridge) (24-11-2015)
    “…TET1/2/3 are methylcytosine dioxygenases that regulate cytosine hydroxymethylation. Tet1/2 are abundantly expressed in HSC/HPCs and are implicated in…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Chromatin regulator Asxl1 loss and Nf1 haploinsufficiency cooperate to accelerate myeloid malignancy by Zhang, Peng, He, Fuhong, Bai, Jie, Yamamoto, Shohei, Chen, Shi, Zhang, Lin, Sheng, Mengyao, Zhang, Lei, Guo, Ying, Man, Na, Yang, Hui, Wang, Suyun, Cheng, Tao, Nimer, Stephen D, Zhou, Yuan, Xu, Mingjiang, Wang, Qian-Fei, Yang, Feng-Chun

    Published in The Journal of clinical investigation (01-12-2018)
    “…ASXL1 is frequently mutated in myeloid malignancies and is known to co-occur with other gene mutations. However, the molecular mechanisms underlying the…”
    Get full text
    Journal Article